UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 221

Sortiert nach

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level

The Journal of pharmacology and experimental therapeutics, 2007-01, Vol.320 (1), p.323

2007

Volltextzugriff (PDF)

Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models

The Journal of pharmacology and experimental therapeutics, 2008-10, Vol.327 (1), p.268

2008

Volltextzugriff (PDF)

KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models

The Journal of pharmacology and experimental therapeutics, 2012-08, Vol.342 (2), p.288

2012

Volltextzugriff (PDF)

The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillance

Expert opinion on drug safety, 2019-12, Vol.18 (12), p.1255-1261

2019

Volltextzugriff (PDF)

Treatment Patterns in Newly Diagnosed Patients with Crohn’s Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan

Digestion, 2023-03, Vol.104 (2), p.109-120

2023

Volltextzugriff (PDF)

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice

European journal of pharmacology, 2009-09, Vol.618 (1-3), p.98-104

2009

Volltextzugriff (PDF)

Novel Insertional Mutation in the Bone Morphogenetic Protein Receptor Type II Associated With Sporadic Primary Pulmonary Hypertension

Circulation Journal, 2004, Vol.68(6), pp.592-594

2004

Volltextzugriff (PDF)

SLC5A9/SGLT4, a new Na +-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose

Life sciences (1973), 2005-01, Vol.76 (9), p.1039-1050

2005

Volltextzugriff (PDF)

Structure–activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

Bioorganic & medicinal chemistry, 2012-11, Vol.20 (22), p.6598-6612

2012

Volltextzugriff (PDF)

Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Bioorganic & medicinal chemistry, 2013-02, Vol.21 (3), p.748-765

2013

Volltextzugriff (PDF)

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A super(y) mice

European journal of pharmacology, 2009-09, Vol.618 (1-3), p.98-104

2009

Volltextzugriff (PDF)

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-Ay mice

European journal of pharmacology, 2009-09, Vol.618 (1-3), p.98-104

2009

Volltextzugriff (PDF)

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A y mice

European journal of pharmacology, 2009, Vol.618 (1), p.98-104

2009

Volltextzugriff (PDF)

Design, synthesis, and structure-activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl I2-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Bioorganic & medicinal chemistry, 2013-02, Vol.21 (3), p.748-765

2013

Volltextzugriff (PDF)

Design, synthesis, and structure-activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl [beta]-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Bioorganic & medicinal chemistry, 2013-02, Vol.21 (3), p.748-765

2013

Volltextzugriff (PDF)

Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl I2-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

Bioorganic & medicinal chemistry, 2012-11, Vol.20 (22), p.6598-6612

2012

Volltextzugriff (PDF)

Corrigendum to “SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro- d-glucitol, and fructose” [Life Sciences 76 (2005) 1039–1050]

Life sciences (1973), 2010-10, Vol.87 (15), p.514-514

2010

Volltextzugriff (PDF)

Anomalously high radon discharge from the atotsugawa fault prior to the western nagano prefecture earthquake ( m 6.8) of september 14, 1984

Tectonophysics, 1988-09, Vol.152 (1), p.147-152

1988

Volltextzugriff (PDF)

Do you feel happy when other members look happy? Moderating effect of community‐level social capital on interconnection of happiness

International journal of psychology, 2021-10, Vol.56 (5), p.642-653

2021

Volltextzugriff (PDF)

Food additive-induced oxidative stress in rat male reproductive organs and hippocampus

Archives of biochemistry and biophysics, 2021-04, Vol.701, p.108810, Article 108810

2021

Volltextzugriff (PDF)

Who commits to the community? Person-community fit, place attachment, and participation in local Japanese communities

Journal of environmental psychology, 2023-03, Vol.86, p.101964, Article 101964

2023

Volltextzugriff (PDF)

Syntheses and characterization of xylan esters

Polymer (Guilford), 2012-08, Vol.53 (18), p.3885-3893

2012

Volltextzugriff (PDF)

Synthesis and characterization of dextran ester derivatives and their adhesive properties

Journal of wood science, 2019-12, Vol.65 (1), p.1-8, Article 66

2019

Volltextzugriff (PDF)

EDITORIAL: TRUST

PSYCHOLOGIA, 2019/12/25, pp.2019-B007

2019

Volltextzugriff (PDF)

Synthesis and characterization of pullulan alkyl esters

European polymer journal, 2015-05, Vol.66, p.470-477

2015

Volltextzugriff (PDF)

1 – 25 von 221

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Englisch
(207)
Japanisch
(75)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level

Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models

KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models

The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillance

Treatment Patterns in Newly Diagnosed Patients with Crohn’s Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice

Novel Insertional Mutation in the Bone Morphogenetic Protein Receptor Type II Associated With Sporadic Primary Pulmonary Hypertension

SLC5A9/SGLT4, a new Na +-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose

Structure–activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A super(y) mice

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-Ay mice

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A y mice

Design, synthesis, and structure-activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl I2-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Design, synthesis, and structure-activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl [beta]-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl I2-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

Corrigendum to “SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro- d-glucitol, and fructose” [Life Sciences 76 (2005) 1039–1050]

Anomalously high radon discharge from the atotsugawa fault prior to the western nagano prefecture earthquake ( m 6.8) of september 14, 1984

Do you feel happy when other members look happy? Moderating effect of community‐level social capital on interconnection of happiness

Food additive-induced oxidative stress in rat male reproductive organs and hippocampus

Who commits to the community? Person-community fit, place attachment, and participation in local Japanese communities

Syntheses and characterization of xylan esters

Synthesis and characterization of dextran ester derivatives and their adhesive properties

EDITORIAL: TRUST

Synthesis and characterization of pullulan alkyl esters

Suchergebnisse filtern